Medicare Enrolled
Dr. Xuanha White, D.O.
Pulmonary Disease · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. White from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. White?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. White
Dr. Xuanha White is a pulmonary disease specialist in San Diego, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. White performed 4,612 Medicare services across 3,484 unique beneficiaries.
Between the years covered by Open Payments, Dr. White received a total of $213,940 from 59 pharmaceutical and/or device companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. White is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 5% volume in CA
$213,940 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,612
Medicare services
Top 5% in CA for pulmonary disease
3,484
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~329 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
712 | $95 | $164 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
464 | $141 | $229 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
448 | $30 | $51 |
| Lung function test for low oxygen response A test that measures how your lungs function in response to low oxygen levels. |
440 | $67 | $108 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
439 | $46 | $75 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
433 | $44 | $71 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
229 | $1 | $2 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
178 | $16 | $25 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
137 | $513 | $810 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
129 | $26 | $43 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
126 | $93 | $188 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
116 | $129 | $213 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
110 | $10 | $18 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
97 | $14 | $23 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
86 | $530 | $834 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
83 | $172 | $810 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
74 | $72 | $208 |
| New patient office visit, complex (60-74 min) | 72 | $173 | $280 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
44 | $48 | $199 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
28 | $127 | $232 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $141 | $219 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
22 | $52 | $223 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
18 | $136 | $252 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
17 | $76 | $186 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
17 | $9 | $66 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
14 | $119 | $248 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves electronically analyzing an implanted neurostimulator generator and performing complex programming for a cranial nerve stimulator. |
14 | $43 | $67 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
13 | $8 | $12 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
13 | $0 | $0 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
11 | $16 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$213,940
Total received (2018-2024)
Avg $30,563/year across 7 years
Top 2% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
708
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161,929 (75.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$35,702 (16.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,310 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$112,151
2023
$37,605
2022
$54,308
2021
$5,222
2020
$1,711
2019
$2,258
2018
$686
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$57,555
AstraZeneca Pharmaceuticals LP
$25,461
Inspire Medical Systems, Inc.
$19,056
GlaxoSmithKline, LLC.
$6,816
INTUITIVE SURGICAL, INC.
$1,704
Regeneron Healthcare Solutions, Inc.
$487
Bayer Healthcare Pharmaceuticals Inc.
$200
ABBVIE INC.
$150
HARMONY BIOSCIENCES LLC
$136
Grifols USA, LLC
$104
SANOFI-AVENTIS U.S. LLC
$79
ERBE USA INC
$74
Pinnacle Biologics, Inc
$64
Paratek Pharmaceuticals, Inc.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$57
Mylan Specialty L.P.
$50
Insmed, Inc.
$30
IDORSIA PHARMACEUTICALS US INC
$24
Philips North America LLC
$23
Baxter Healthcare
$21
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$82,502
GENZYME CORPORATION
$58,139
Inspire Medical Systems, Inc.
$37,440
GlaxoSmithKline, LLC.
$21,304
Pinnacle Biologics, Inc
$3,312
INTUITIVE SURGICAL, INC.
$1,704
Regeneron Healthcare Solutions, Inc.
$1,173
Boehringer Ingelheim Pharmaceuticals, Inc.
$850
Intuitive Surgical, Inc.
$612
Paratek Pharmaceuticals, Inc.
$603
Grifols USA, LLC
$397
United Therapeutics Corporation
$382
Neurocrine Biosciences, Inc.
$380
ABBVIE INC.
$339
Philips Electronics North America Corporation
$285
Takeda Pharmaceuticals U.S.A., Inc.
$260
JAZZ PHARMACEUTICALS INC.
$247
Pulmonx Corporation
$238
Mylan Specialty L.P.
$238
Advanced Respiratory, Inc
$236
ITI, Inc.
$219
Bayer Healthcare Pharmaceuticals Inc.
$200
HARMONY BIOSCIENCES LLC
$190
Insmed, Inc.
$177
Sunovion Pharmaceuticals Inc.
$165
Respicardia, Inc.
$164
SANOFI-AVENTIS U.S. LLC
$159
Eisai Inc.
$151
La Jolla Pharmaceutical Company
$150
Amgen Inc.
$147
Olympus America Inc.
$135
Harmony Biosciences LLC
$126
Inari Medical, Inc.
$124
Shire North American Group Inc
$88
ARBOR PHARMACEUTICALS, INC.
$84
Arbor Pharmaceuticals, Inc.
$82
Genentech USA, Inc.
$77
IDORSIA PHARMACEUTICALS US INC
$74
ERBE USA INC
$74
ABIOMED
$74
Azurity Pharmaceuticals, Inc.
$70
Merck Sharp & Dohme LLC
$70
Jazz Pharmaceuticals Inc.
$61
Veran Medical Technologies, Inc.
$54
Baxter Healthcare
$48
Axsome Therapeutics, Inc.
$42
CSL Behring
$37
Electromed, Inc.
$34
Gilead Sciences, Inc.
$33
Acerta Pharma LLC
$28
Philips North America LLC
$23
ADVANCED RESPIRATORY, INC
$20
Melinta Therapeutics, LLC
$19
Circassia Pharmaceuticals Inc
$19
Fisher & Paykel Healthcare Inc
$19
Merck Sharp & Dohme Corporation
$18
Allergan Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 83.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (9360) DS2A A cell FG · (O58) Sleep Respiratory Care Und · 120V · 60Hz · ABILIFY MAINTENA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CAPLYTA · CHARTIS CATHETER · Cryo 2 · DALVANCE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dayvigo · DreamStat Cpap Auto · Esbriet · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INGREZZA · INSPIRE · Impella · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · Life 2000 Ventilation System · NONE · NUCALA · NUZYRA · OFEV · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Photofrin · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · S · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · Sunosi · SynclaraCough System · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · VRAYLAR · Vabomere · Veklury · WAKIX · Wakix · Wellcentive Undiv · XYREM · XYWAV · Xembify · Xolair · YUPELRI · Yupelri · Zemaira · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in CA.
Geographic Context
Pulmonary diseases within 10 mi
118
Per 100K population
3.6
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. White is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 2% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. White experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. White performed 712 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. White receive payments from pharmaceutical companies?
Yes. Dr. White received a total of $213,940 from 59 companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. White's costs compare to other pulmonary diseases in San Diego?
Dr. White's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. White) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in San Diego
Browse pulmonary diseases in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Inspire Medical Systems, Inc. Payments to Doctors
See all physicians who received payments from Inspire Medical Systems, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology